Citius Oncology Inc (CTOR)

06:35 AM

Why Citius Oncology Inc. stock attracts global investors2025 Price Targets & Low Drawdown Momentum Ideas - ulpravda.ru

06:35 AM

05:35 AM

How buybacks impact Citius Oncology Inc. stock valueEarnings Growth Report & Expert Curated Trade Setups - ulpravda.ru

05:35 AM

04:17 AM

Aug Sectors: Why Citius Oncology Inc. stock attracts global investorsTrade Analysis Report & Weekly Watchlist of Top Performers - ulpravda.ru

04:17 AM

11:48 AM

Does Citius Oncology Inc. stock trade at a discount to peersMarket Risk Report & Momentum Based Trading Signals - ulpravda.ru

11:48 AM

Jan 06, 2026

Citius Oncology raises $18M through direct offering - MSN

Jan 06, 2026

Jan 05, 2026

Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citius Oncology, Inc. (NASDQ: CTOR) - marketscreener.com

Jan 05, 2026

Jan 05, 2026

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citius Oncology, Inc. (NASDQ: CTOR) - Prime Publishers, Inc.

Jan 05, 2026

Jan 03, 2026

Citius Oncology announces pricing of $9 million public offering - MSN

Jan 03, 2026

Jan 02, 2026

What drives Citius Oncology Inc stock priceVolatility Trading Techniques & You’ve Never Seen Stock Picks Like These - earlytimes.in

Jan 02, 2026

Jan 02, 2026

Is Citius Oncology Inc a good long term investmentBear Market Strategies & Low Entry Risk Stocks - earlytimes.in

Jan 02, 2026

Dec 31, 2025

Earnings Miss: Will Citius Oncology Inc stock sustain high P E ratiosJuly 2025 Institutional & Verified Technical Signals - moha.gov.vn

Dec 31, 2025

Dec 29, 2025

Citius Oncology, Inc. (NASDAQ:CTOR) Sees Significant Increase in Short Interest - Defense World

Dec 29, 2025

Dec 28, 2025

Press Release: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update - 富途牛牛

Dec 28, 2025

Dec 26, 2025

Citius Oncology, Inc. (NASDAQ:CTOR) Short Interest Update - MarketBeat

Dec 26, 2025

Dec 26, 2025

Citius Oncology (CTOR) Stock Analysis Report | Financials & Insights - Benzinga France

Dec 26, 2025

Dec 26, 2025

Citius Oncology’s LYMPHIR FDA Win Clouded by High Upfront Costs, Regulatory Risks, and Uncertain Market Adoption - TipRanks

Dec 26, 2025

Dec 24, 2025

Citius Pharmaceuticals (CTXR) Surges 22% After Hours — Here's Why - Benzinga

Dec 24, 2025

Dec 23, 2025

Citius Oncology, Inc. Full Year Loss Increases - Nasdaq

Dec 23, 2025

Dec 23, 2025

Citius Oncology Transitions to Commercial Stage: Analyzing the 10-K Filing and the 2026 Outlook for LYMPHIR - FinancialContent

Dec 23, 2025

Dec 23, 2025

Citius Oncology (NASDAQ:CTOR) Issues Quarterly Earnings Results - MarketBeat

Dec 23, 2025

Dec 23, 2025

Citius Oncology Fiscal 2025 Loss Widens - marketscreener.com

Dec 23, 2025

Dec 23, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update - WV News

Dec 23, 2025

Dec 23, 2025

Citius Pharmaceuticals, Inc. SEC 10-K Report - TradingView — Track All Markets

Dec 23, 2025

Dec 23, 2025

Citius Oncology, Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 - marketscreener.com

Dec 23, 2025

Dec 22, 2025

Citius Oncology : Amendment to Statement of Changes in Beneficial Ownership (Form 4/A) - marketscreener.com

Dec 22, 2025

Dec 18, 2025

Citius Oncology Earnings Notes - Trefis

Dec 18, 2025

Dec 18, 2025

Citius Oncology, Inc.(NasdaqCM: CTOR) added to Russell 3000E Value Index - marketscreener.com

Dec 18, 2025

Dec 12, 2025

Citius Oncology (CTOR) Price Target Increased by 100.00% to 6.12 - MSN

Dec 12, 2025

Dec 11, 2025

Citius Oncology closes $18 million in offerings to support LYMPHIR launch - Investing.com Nigeria

Dec 11, 2025

Dec 10, 2025

Citius Oncology Raises $18M Through Direct Offering - TipRanks

Dec 10, 2025

Dec 10, 2025

Citius Oncology Announces Closing of $18 Million Concurrent Regi - GuruFocus

Dec 10, 2025

Dec 10, 2025

Citius Oncology closes $18 million in offerings to support LYMPHIR launch By Investing.com - Investing.com South Africa

Dec 10, 2025

Dec 10, 2025

Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules - Barchart.com

Dec 10, 2025

Dec 10, 2025

Citius Oncology (NASDAQ:CTOR) Shares Up 6.4%What's Next? - MarketBeat

Dec 10, 2025

Dec 09, 2025

Citius Oncology raises $18 million to support cancer therapy launch By Investing.com - Investing.com Canada

Dec 09, 2025

Dec 09, 2025

Citius Oncology, Inc. announced that it has received $16.6 million in funding - marketscreener.com

Dec 09, 2025

Dec 09, 2025

Citius Oncology (NASDAQ: CTOR) raises $1.4M, adds large warrant package - Stock Titan

Dec 09, 2025

Dec 09, 2025

Citius Oncology added to the Russell Microcap Index - MSN

Dec 09, 2025

Dec 09, 2025

Citius Oncology shares sink after announcing $18M fundraising deal - MSN

Dec 09, 2025

Dec 09, 2025

Citius Oncology raises $18 million to support cancer therapy launch - Investing.com

Dec 09, 2025

Dec 09, 2025

Citius Oncology stock tumbles after $18M capital raise By Investing.com - Investing.com Nigeria

Dec 09, 2025

Dec 09, 2025

Citius Oncology stock tumbles after $18M capital raise - Investing.com India

Dec 09, 2025

Dec 09, 2025

Citius Oncology announces $18 million concurrent registered direct offering and private placement priced at-the-market under Nasdaq rules - marketscreener.com

Dec 09, 2025

Dec 09, 2025

Press Release: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules - 富途牛牛

Dec 09, 2025

Dec 07, 2025

Citius Oncology, Inc. announced that it expects to receive $16.6 million in funding - marketscreener.com

Dec 07, 2025

Dec 05, 2025

Citius Oncology Launches Lymphir In US For Skin Cancer - MSN

Dec 05, 2025

Dec 05, 2025

Citius Oncology expands lymphir distribution to Turkey, Middle East By Investing.com - Investing.com Nigeria

Dec 05, 2025

Dec 05, 2025

Is Citius Oncology Inc. stock a top pick in earnings season2025 Dividend Review & Weekly Top Gainers Alerts - Newser

Dec 05, 2025